GB1149648A - Sterilisation of solids for use in aqueous suspensions - Google Patents
Sterilisation of solids for use in aqueous suspensionsInfo
- Publication number
- GB1149648A GB1149648A GB3953666A GB3953666A GB1149648A GB 1149648 A GB1149648 A GB 1149648A GB 3953666 A GB3953666 A GB 3953666A GB 3953666 A GB3953666 A GB 3953666A GB 1149648 A GB1149648 A GB 1149648A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acetate
- sodium chloride
- excess
- sterilising
- sept
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000007900 aqueous suspension Substances 0.000 title abstract 2
- 239000007787 solid Substances 0.000 title abstract 2
- 238000004659 sterilization and disinfection Methods 0.000 title abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 8
- 239000011780 sodium chloride Substances 0.000 abstract 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 abstract 3
- 230000001954 sterilising effect Effects 0.000 abstract 3
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 abstract 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 abstract 2
- 238000010438 heat treatment Methods 0.000 abstract 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012047 saturated solution Substances 0.000 abstract 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 abstract 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 229920001213 Polysorbate 20 Polymers 0.000 abstract 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 229960000686 benzalkonium chloride Drugs 0.000 abstract 1
- 235000019445 benzyl alcohol Nutrition 0.000 abstract 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 abstract 1
- 229960004648 betamethasone acetate Drugs 0.000 abstract 1
- AKUJBENLRBOFTD-QZIXMDIESA-N betamethasone acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(C)=O)(O)[C@@]1(C)C[C@@H]2O AKUJBENLRBOFTD-QZIXMDIESA-N 0.000 abstract 1
- 239000001768 carboxy methyl cellulose Substances 0.000 abstract 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 abstract 1
- 239000002738 chelating agent Substances 0.000 abstract 1
- 229940109239 creatinine Drugs 0.000 abstract 1
- 229960003957 dexamethasone Drugs 0.000 abstract 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003792 electrolyte Substances 0.000 abstract 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 abstract 1
- 229960000890 hydrocortisone Drugs 0.000 abstract 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 abstract 1
- 229960000905 indomethacin Drugs 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000000787 lecithin Substances 0.000 abstract 1
- 235000010445 lecithin Nutrition 0.000 abstract 1
- 229940067606 lecithin Drugs 0.000 abstract 1
- 229960004194 lidocaine Drugs 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 229960001293 methylprednisolone acetate Drugs 0.000 abstract 1
- PLBHSZGDDKCEHR-LFYFAGGJSA-N methylprednisolone acetate Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(C)=O)CC[C@H]21 PLBHSZGDDKCEHR-LFYFAGGJSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000011236 particulate material Substances 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 abstract 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 abstract 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- 235000010356 sorbitol Nutrition 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 239000000375 suspending agent Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- WMOVHXAZOJBABW-UHFFFAOYSA-N tert-butyl acetate Chemical compound CC(=O)OC(C)(C)C WMOVHXAZOJBABW-UHFFFAOYSA-N 0.000 abstract 1
- 229960002117 triamcinolone acetonide Drugs 0.000 abstract 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48559265A | 1965-09-07 | 1965-09-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1149648A true GB1149648A (en) | 1969-04-23 |
Family
ID=23928732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB3953666A Expired GB1149648A (en) | 1965-09-07 | 1966-09-05 | Sterilisation of solids for use in aqueous suspensions |
Country Status (5)
Country | Link |
---|---|
DE (1) | DE1617628B1 (enrdf_load_stackoverflow) |
ES (1) | ES331228A1 (enrdf_load_stackoverflow) |
FR (1) | FR1546469A (enrdf_load_stackoverflow) |
GB (1) | GB1149648A (enrdf_load_stackoverflow) |
NL (1) | NL159010B (enrdf_load_stackoverflow) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007089490A1 (en) * | 2006-01-27 | 2007-08-09 | Elan Pharma International, Ltd. | Sterilized nanoparticulate glucocorticosteroid formulations |
WO2016092513A1 (en) | 2014-12-12 | 2016-06-16 | Alfa Intes Industria Terapeutica Splendore S.R.L. | Ophthalmic compositions for use in the treatment of the dry eye syndrome |
CN115487153A (zh) * | 2022-10-25 | 2022-12-20 | 成都青山利康药业股份有限公司 | 一种保护化合物的晶型的方法 |
CN115969784A (zh) * | 2022-12-26 | 2023-04-18 | 昆明积大制药股份有限公司 | 曲安奈德注射液的制备方法 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5537528B2 (enrdf_load_stackoverflow) * | 1972-12-11 | 1980-09-29 | ||
FR2657018A1 (fr) * | 1990-01-12 | 1991-07-19 | Merck Sharp & Dohme | Composition ophtalmique fluide a base de microparticules lipidiques contenant au moins un principe actif et son procede de preparation. |
DE102005009194B4 (de) * | 2005-03-01 | 2006-12-14 | Hpp-Hommel Pharmaceuticals Production Gmbh | Verfahren zur Herstellung von polymorph stabilem Triamcinolonacetonid |
-
1966
- 1966-08-31 FR FR47839A patent/FR1546469A/fr not_active Expired
- 1966-09-01 ES ES0331228A patent/ES331228A1/es not_active Expired
- 1966-09-05 GB GB3953666A patent/GB1149648A/en not_active Expired
- 1966-09-06 DE DE1966M0070838 patent/DE1617628B1/de active Pending
- 1966-09-07 NL NL6612607A patent/NL159010B/xx not_active IP Right Cessation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007089490A1 (en) * | 2006-01-27 | 2007-08-09 | Elan Pharma International, Ltd. | Sterilized nanoparticulate glucocorticosteroid formulations |
WO2016092513A1 (en) | 2014-12-12 | 2016-06-16 | Alfa Intes Industria Terapeutica Splendore S.R.L. | Ophthalmic compositions for use in the treatment of the dry eye syndrome |
CN115487153A (zh) * | 2022-10-25 | 2022-12-20 | 成都青山利康药业股份有限公司 | 一种保护化合物的晶型的方法 |
CN115487153B (zh) * | 2022-10-25 | 2023-11-03 | 成都青山利康药业股份有限公司 | 一种保护化合物的晶型的方法 |
CN115969784A (zh) * | 2022-12-26 | 2023-04-18 | 昆明积大制药股份有限公司 | 曲安奈德注射液的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
FR1546469A (fr) | 1968-11-22 |
NL6612607A (enrdf_load_stackoverflow) | 1967-03-08 |
DE1617628B1 (de) | 1971-01-21 |
NL159010B (nl) | 1979-01-15 |
ES331228A1 (es) | 1967-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU229800B1 (en) | Stabilized aqueous suspensions for parenteral use containing steroids | |
US2861920A (en) | Therapeutic suspensions of steroids containing pvp and/or pva | |
US3337412A (en) | Topical fluoride-phosphate compositions and method | |
ES2166905T3 (es) | Composiciones que incluyen o-carboxialquilquitosano y metodos de uso en productos oftalmicos. | |
GB1446352A (en) | Pharmaceutical compositions | |
GB1190112A (en) | Method of making a Solid Dispersing and Stabilizing Agent | |
ES2031467T3 (es) | Formulaciones acuosas de esteroides apropiadas para administracion por via nasal. | |
CA2257841A1 (en) | Medicinal aerosol formulations of formoterol | |
GB1149648A (en) | Sterilisation of solids for use in aqueous suspensions | |
HU172709B (hu) | Sposob poluchenija proizvodnykh difenil efirov, i gerbicidnykh kompozicijj soderzhahhikh ikh aktivnymiagentami | |
ATE66605T1 (de) | Waessrige arzneiformulierungen des piroxicammonohydrats. | |
IL42781A (en) | Derivatives of(4'-(3"-indolyl)piperidino)alkylarylketones,process for preparing them and pharmaceutical compositions containing same | |
US3008875A (en) | Neomycin and mirystyl-gamma-picolinium halide compositions | |
GB1411432A (en) | Skin treating compositions | |
ES468301A1 (es) | Procedimiento para la preparacion de una emulsion de sustan-cias medicamentosas para instilacion | |
IL25251A (en) | Aqueous mixtures for ophthalmology based on hydroxyethylcellulose and a method for their preparation | |
ES2126579T3 (es) | Comprimidos de dispersion solida que contienen derivados de 1,4-dihidropiridina y procedimiento para su preparacion. | |
ES473300A1 (es) | Un procedimiento para la preparacion de una composicion cos-metica con actividad antiseborreica | |
GB2169508A (en) | Ophthalmic solutions containing hydroxyethyl cellulose | |
EA009843B1 (ru) | Содержащая циклесонид стерильная водная суспензия | |
JPH08295622A (ja) | 再分散性の優れたイオン性高分子配合水性懸濁点眼剤 | |
GB1481411A (en) | Pharmaceutical compositions | |
GB1270614A (en) | Stable aqueous steroid phosphate solutions | |
US3415929A (en) | Ophthalmic solution containing poly-1,3-beta-glucoside | |
US3138528A (en) | Stable, aqueous solutions of 21-phosphate esters of 21-hydroxy steroids |